| 前收市價 | 163.62 |
| 開市 | 163.92 |
| 買盤 | 162.27 x 100 |
| 賣出價 | 163.23 x 100 |
| 今日波幅 | 162.67 - 166.54 |
| 52 週波幅 | 93.95 - 189.97 |
| 成交量 | |
| 平均成交量 | 372,871 |
| 市值 | 4.65B |
| Beta 值 (5 年，每月) | 0.90 |
| 市盈率 (最近 12 個月) | 74.69 |
| 每股盈利 (最近 12 個月) | 2.18 |
| 業績公佈日 | 2024年8月05日 - 2024年8月09日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 189.00 |
ZacksEarnings Estimates Moving Higher for Krystal Biotech (KRYS): Time to Buy?
Krystal Biotech (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ZacksKrystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Krystal Biotech (KRYS) soars 36.5% on strong uptake of its newly approved drug Vyjuvek and encouraging pipeline progress.
Insider MonkeyKrystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript May 6, 2024 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $0.03182 EPS, expectations were $0.2. Krystal Biotech, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […]
